Anxiolytic-like effects of mitragynine in the open-field and elevated plus-maze tests in rats. 2014

Ammar Imad Hazim, and Surash Ramanathan, and Suhanya Parthasarathy, and Mustapha Muzaimi, and Sharif Mahsufi Mansor
Centre for Drug Research, Universiti Sains Malaysia, 11800, Penang, Malaysia, aijanabi@yahoo.com.

The effects of mitragynine on anxiety-related behaviours in the open-field and elevated plus-maze tests were evaluated. Male Sprague-Dawley rats were orally treated with mitragynine (10, 20 and 40 mg/kg) or diazepam (10 mg/kg) 60 min before behavioural testing. Mitragynine doses used in this study were selected on the basis of approximately human equivalent doses with reference to our previous literature reports. Acute administration of mitragynine (10, 20 and 40 mg/kg) or diazepam (10 mg/kg) increased central zone and open arms exploration in the open-field and elevated plus-maze tests respectively. These anxiolytic-like effects of mitragynine were effectively antagonized by intraperitoneal administration of naloxone (2 mg/kg), flumazenil (10 mg/kg), sulpiride (0.5 mg/kg) or SCH 23390 (0.02 mg/kg) 15 min before mitragynine treatments. These findings reveal that the acute administration of mitragynine produces anxiolytic-like effects and this could be possibly attributed to the interactions among opioidergic, GABAergic and dopaminergic systems in brain regions involved in anxiety.

UI MeSH Term Description Entries
D008297 Male Males
D009043 Motor Activity Body movements of a human or an animal as a behavioral phenomenon. Activities, Motor,Activity, Motor,Motor Activities
D009292 Narcotic Antagonists Agents inhibiting the effect of narcotics on the central nervous system. Competitive Opioid Antagonist,Narcotic Antagonist,Opioid Antagonist,Opioid Antagonists,Opioid Receptor Antagonist,Opioid Reversal Agent,Competitive Opioid Antagonists,Opioid Receptor Antagonists,Opioid Reversal Agents,Agent, Opioid Reversal,Agents, Opioid Reversal,Antagonist, Competitive Opioid,Antagonist, Narcotic,Antagonist, Opioid,Antagonist, Opioid Receptor,Antagonists, Competitive Opioid,Antagonists, Narcotic,Antagonists, Opioid,Antagonists, Opioid Receptor,Opioid Antagonist, Competitive,Opioid Antagonists, Competitive,Receptor Antagonist, Opioid,Receptor Antagonists, Opioid,Reversal Agent, Opioid,Reversal Agents, Opioid
D001921 Brain The part of CENTRAL NERVOUS SYSTEM that is contained within the skull (CRANIUM). Arising from the NEURAL TUBE, the embryonic brain is comprised of three major parts including PROSENCEPHALON (the forebrain); MESENCEPHALON (the midbrain); and RHOMBENCEPHALON (the hindbrain). The developed brain consists of CEREBRUM; CEREBELLUM; and other structures in the BRAIN STEM. Encephalon
D003975 Diazepam A benzodiazepine with anticonvulsant, anxiolytic, sedative, muscle relaxant, and amnesic properties and a long duration of action. Its actions are mediated by enhancement of GAMMA-AMINOBUTYRIC ACID activity. 7-Chloro-1,3-dihydro-1-methyl-5-phenyl-2H-1,4-benzodiazepin-2-one,Apaurin,Diazemuls,Faustan,Relanium,Seduxen,Sibazon,Stesolid,Valium
D004195 Disease Models, Animal Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases. Animal Disease Model,Animal Disease Models,Disease Model, Animal
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001007 Anxiety Feelings or emotions of dread, apprehension, and impending disaster but not disabling as with ANXIETY DISORDERS. Angst,Anxiousness,Hypervigilance,Nervousness,Social Anxiety,Anxieties, Social,Anxiety, Social,Social Anxieties
D001522 Behavior, Animal The observable response an animal makes to any situation. Autotomy Animal,Animal Behavior,Animal Behaviors

Related Publications

Ammar Imad Hazim, and Surash Ramanathan, and Suhanya Parthasarathy, and Mustapha Muzaimi, and Sharif Mahsufi Mansor
March 2017, Neuroscience letters,
Ammar Imad Hazim, and Surash Ramanathan, and Suhanya Parthasarathy, and Mustapha Muzaimi, and Sharif Mahsufi Mansor
December 2008, Fundamental & clinical pharmacology,
Ammar Imad Hazim, and Surash Ramanathan, and Suhanya Parthasarathy, and Mustapha Muzaimi, and Sharif Mahsufi Mansor
January 2014, BioMed research international,
Ammar Imad Hazim, and Surash Ramanathan, and Suhanya Parthasarathy, and Mustapha Muzaimi, and Sharif Mahsufi Mansor
February 2004, Pharmacology, biochemistry, and behavior,
Ammar Imad Hazim, and Surash Ramanathan, and Suhanya Parthasarathy, and Mustapha Muzaimi, and Sharif Mahsufi Mansor
January 2011, Pharmacological reports : PR,
Ammar Imad Hazim, and Surash Ramanathan, and Suhanya Parthasarathy, and Mustapha Muzaimi, and Sharif Mahsufi Mansor
October 2004, Life sciences,
Ammar Imad Hazim, and Surash Ramanathan, and Suhanya Parthasarathy, and Mustapha Muzaimi, and Sharif Mahsufi Mansor
June 2012, European journal of pharmacology,
Ammar Imad Hazim, and Surash Ramanathan, and Suhanya Parthasarathy, and Mustapha Muzaimi, and Sharif Mahsufi Mansor
January 1996, Pharmacological research,
Ammar Imad Hazim, and Surash Ramanathan, and Suhanya Parthasarathy, and Mustapha Muzaimi, and Sharif Mahsufi Mansor
September 2005, Biological & pharmaceutical bulletin,
Ammar Imad Hazim, and Surash Ramanathan, and Suhanya Parthasarathy, and Mustapha Muzaimi, and Sharif Mahsufi Mansor
July 1993, European journal of pharmacology,
Copied contents to your clipboard!